Orphan Therapeutics Accelerator In-Licenses Investigational Gene Therapy Program for Ornithine Transcarbamylase Deficiency from UCL Ventures and Children's Medical Research Institute

Next
Next

Orphan Therapeutics Accelerator Appoints Angela Tom as Head of Medical Affairs